ArticleDiscover oncology2026

Integrative bioinformatics and molecular simulations identify HMGB3 as a key immune modulator in triple negative breast cancer.

Uma Chaudhary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.